Erkut Borazanci
- Oncology top 5%
- Molecular Biology top 10%
- Cancer Research top 5%
- Immunology top 10%
- Epidemiology
- Co-authors
- Daniel D. Von HoffHaiyong HanPawan NoelAshok K. SalujaGayle JamesonMark H. O’HaraPeter J. O’DwyerDaniel A. Laheru
- Topics
- Pancreatic and Hepatic Oncology Research (57 papers)Cancer Immunotherapy and Biomarkers (22 papers)Cancer Genomics and Diagnostics (19 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaGastroenterology
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Erkut Borazanci
98 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Oncology 974
- Molecular Biology 838
- Cancer Research 628
- Immunology 344
- Epidemiology 226
Countries citing papers authored by Erkut Borazanci
This map shows the geographic impact of Erkut Borazanci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erkut Borazanci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erkut Borazanci more than expected).
Fields of papers citing papers by Erkut Borazanci
This network shows the impact of papers produced by Erkut Borazanci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erkut Borazanci. The network helps show where Erkut Borazanci may publish in the future.
Co-authorship network of co-authors of Erkut Borazanci
This figure shows the co-authorship network connecting the top 25 collaborators of Erkut Borazanci. A scholar is included among the top collaborators of Erkut Borazanci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erkut Borazanci. Erkut Borazanci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 4 | |
| 7 | 4 | |
| 8 | 20 | |
| 9 | 5 | |
| 10 | 5 | |
| 11 | 2 | |
| 12 | First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumorsbreakdown → | 192 |
| 13 | 2 | |
| 14 | 161 | |
| 15 | Triptolide and Its Derivatives as Cancer Therapiesbreakdown → | 233 |
| 16 | 66 | |
| 17 | 26 | |
| 18 | 32 | |
| 19 | 21 | |
| 20 | 45 |
About Erkut Borazanci
Erkut Borazanci is a scholar working on Oncology, Cancer Research and Biotechnology, having authored 104 papers that have together received 1.9k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (57 papers), Cancer Immunotherapy and Biomarkers (22 papers) and Cancer Genomics and Diagnostics (19 papers). The work is most often cited by research in Cancer Research (628 citations), Oncology (974 citations) and Complementary and alternative medicine (138 citations). Erkut Borazanci has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Daniel D. Von Hoff, Haiyong Han, Pawan Noel, Ashok K. Saluja, Gayle Jameson, Mark H. O’Hara, Peter J. O’Dwyer, Daniel A. Laheru, Kim A. Reiss and Ana De Jesus‐Acosta. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.